Litigation
Ascendis Pharma A/S et al. v. BioMarin Pharmaceutical Inc.
voluntarily dismissed4:25-cv-03302
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2025-04-11
- Terminated
- 2025-07-07
Patents at issue (1)
Defendants (1)
Summary
Ascendis entities filed a declaratory judgment action of non-infringement against BioMarin, also invoking the 35 U.S.C. § 271(e)(1) safe harbor. Ascendis voluntarily dismissed without prejudice on July 7, 2025, stating it would refile to seek a mandatory stay under 28 U.S.C. § 1659(a)(2).
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).